• Cost-Effectiveness Aspects of Defibrillators: Decreasing the Financial Burden

    Decreasing the Financial Burden The financial burden on society to treat and prevent sudden cardiac death (SCD) is enormous. ICDs effectively reduce SCD and are recommended for secondary and primary prevention of SCD from VT/VF. Unfortunately, ICDs are expensive and add to demands to healthcare budgets in even the most developed nations....

    READ MORE
  • Evidence-Based Purchasing in Cardiology: Cost-Effective Healthcare Technology Assessments

    The Centre for Evidence-based Purchasing (CEP) was created within the UK National Health Service (NHS) Purchasing and Supply Agency (PASA). Funded by the UK Department of Health (DH) it delivers free, independent and impartial evidence to healthcare providers to underpin purchasing decisions and to drive adoption of useful, innovative healthcare technologies...

    READ MORE
  • Interview with Prof. P. Brugada

    Prof. Pedro Brugada tells Cardiology Management about the public and private achievements that have shaped his career in cardiology. We also learn about the scientific legacy left by himself and his brothers, as the first to describe ‘Brugada syndrome’, a hereditary disease characterised by sudden cardiac death caused by severe disturbances of...

    READ MORE
  • Leadership and Coaching in the Healthcare Arena: What You Need to Know

    Understanding the Emotional Tools Required to Lead Your Team In normal praxis, people are promoted to a position of management or leadership due to their effort, results or good performance.They become leaders by default. But when they get there they soon realise that leadership takes something more than reaching goals or showing good intentions....

    READ MORE
  • Editorial

    Dear Readers, For two thousand years, the oath of Hippocrates has bound its proponents to uphold the highest of professional standards in treating patients. This inviolable commitment continues today and clearly delineates the duties of our vocation. Nevertheless, much has changed today in comparison with ancient medicine. Modern medical...

    READ MORE
  • EC-Funded E-Health Study Looks at Progress and Barriers

    A new study funded by the European Commission is assessing the progress made to date, towards the realisation of European e-Health Action Plan goals. Good practices and lessons learned constitute the study’s key elements. The results will be fed into policy recommendations for further accelerating e-Health implementation. The study...

    READ MORE
  • Siemens Demonstrate Intra-Cardiac Echocardiography Catheter

    Siemens showed off their ACUSON AcuNav V, the world’s first intra-cardiac echocardiography catheter for volume imaging, at the 2009 Scientific Sessions of the Heart Rhythm Society in Boston, MA, USA. With real-time volumetric information from inside the heart, the new ACUSON AcuNav V volume catheter is said to improve therapeutic ablation procedures...

    READ MORE
  • Optimising Access to Cardiovascular Technology in Europe:The Case for Device Implantation Rates

    Equitable access to healthcare forms one of the common objectives for EU Member States in the fight against social exclusion and poverty, yet barriers remain in the way of goals for optimum and homogenous access. For medical technologies, these barriers to access can be multi-factorial, yet broadly classified as stemming from the supply or demand...

    READ MORE
  • Profile of the American Heart Association: Building Healthier Lives

    The American heart association mission is building healthier lives, free of cardiovascular diseases and stroke. To accomplish this, its volunteers and organisation are involved in an extremely broad range of activities. The activities of the Association systematically attack the problem of cardiovascular disease across the knowledge spectrum...

    READ MORE
  • Anticlotting Medicine Lowers Incidence of Heart Attack

    New data shows anticlotting medicine Tirofiban (AGGRASTAT®) lowers incidence of heart attack in patients who respond poorly to aspirin or Clopidogrel after elective coronary angioplasty. Dr Marco Valgimigli, Chair of Cardiology, University of Ferrara, Italy and the principal investigator of the study emphasised the significance of the findings as they...

    READ MORE
Subscribe To The Cardiology Management Channel